|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, Lam
CM and Wong J: Improving survival results after resection of
hepatocellular carcinoma: A prospective study of 377 patients over
10 years. Ann Surg. 234:63–70. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Poon RT, Ng IO, Fan ST, Lai EC, Lo CM, Liu
CL and Wong J: Clinicopathologic features of long-term survivors
and disease-free survivors after resection of hepatocellular
carcinoma: A study of a prospective cohort. J Clin Oncol.
19:3037–3044. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Katz SC, Shia J, Liau KH, Gonen M, Ruo L,
Jarnagin WR, Fong Y, D'Angelica MI, Blumgart LH and Dematteo RP:
Operative blood loss independently predicts recurrence and survival
after resection of hepatocellular carcinoma. Ann Surg. 249:617–623.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Arii S, Tanaka J, Yamazoe Y, Minematsu S,
Morino T, Fujita K, Maetani S and Tobe T: Predictive factors for
intrahepatic recurrence of hepatocellular carcinoma after partial
hepatectomy. Cancer. 69:913–919. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yanaga K: Current status of hepatic
resection for hepatocellular carcinoma. J Gastroenterol.
39:919–926. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shiba H, Ishida Y, Wakiyama S, Iida T,
Matsumoto M, Sakamoto T, Ito R, Gocho T, Furukawa K, Fujiwara Y,
Hirohara S, et al: Negative impact of blood transfusion on
recurrence and prognosis of hepatocellular carcinoma after hepatic
resection. J Gastrointest Surg. 13:1636–1642. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tandon P and Garcia-Tsao G: Prognostic
indicators in hepatocellular carcinoma: A systematic review of 72
studies. Liver Int. 29:502–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McMillian DC, Crozier JE, Canna K,
Angerson WJ and McArdle CS: Evaluation of an inflammation-based
prognostic score (GPS) in patients undergoing resection for colon
and rectal cancer. Int J Colorectal Dis. 22:881–886. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Crumley AB, McMillan DC, McKernan M, Going
JJ, Shearer CJ and Stuart RC: An elevated C-reactive protein
concentration, prior to surgery, predicts poor cancer-specific
survival in patients undergoing resection for gastro-oesophageal
cancer. Br J Cancer. 94:1568–1571. 2006.PubMed/NCBI
|
|
11
|
Hilmy M, Bartlett JM, Underwood MA and
McMillan DC: The relationship between the systemic inflammatory
response and survival in patients with transitional cell carcinoma
of the urinary bladder. Br J Cancer. 92:625–627. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jamieson NB, Glen P, McMillan DC, McKay
CJ, Foulis AK, Carter R and Imrie CW: Systemic inflammatory
response predicts outcome in patients undergoing resection for
ductal adenocarcinoma head of pancreas. Br J Cancer. 92:21–23.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lamb GW, Aitchison M, Ramsey S, Housley SL
and McMillan DC: Clinical utility of the Glasgow Prognostic Score
in patients undergoing curative nephrectomy for renal clear cell
cancer: Basis of new prognostic scoring systems. Br J Cancer.
106:279–283. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hara M, Matsuzaki Y, Shimuzu T, Tomita M,
Ayabe T, Enomoto Y and Onitsuka T: Preoperative serum C-reactive
protein level in non-small cell lung cancer. Anticancer Res.
27:3001–3004. 2007.PubMed/NCBI
|
|
15
|
Shiba H, Misawa T, Fujiwara Y, Futagawa Y,
Furukawa K, Haruki K, Iwase R, Wakiyama S, Ishida Y and Yanaga K:
Glasgow prognostic score predicts therapeutic outcome after
pancreaticoduodenectomy for carcinoma of the ampulla of vater.
Anticancer Res. 33:2715–2721. 2013.PubMed/NCBI
|
|
16
|
Shiba H, Iwase R, Futagawa Y, Futagawa Y,
Furukawa K, Haruki K, Iwase R, Iida T and Yanaga K: Glasgow
prognostic score predicts therapeutic outcome after surgical
resection for gallbladder cancer. World J Surg. 39:753–758. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Furukawa K, Shiba H, Haruki K, Fujiwara Y,
Iida T, Mitsuyama Y, Ogawa M, Ishida Y, Misawa T and Yanaga K: The
Glasgow prognostic score is valuable for colorectal cancer with
both synchronous and metachronous unresectable liver metastases.
Oncol Lett. 4:324–328. 2012.PubMed/NCBI
|
|
18
|
Ishizuka M, Kubota K, Kita J, Shimoda M,
Kato M and Sawada T: Impact of an inflammation-based prognostic
system on patients undergoing surgery for hepatocellular carcinoma:
A retrospective study of 398 Japanese patients. Am J Surg.
203:101–106. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Horino K, Beppu T, Kuroki H, Mima K, Okabe
H, Nakahara O, Ikuta Y, Chikamoto A, Ishiko T, Takamori H and Baba
H: Glasgow prognostic score as a useful prognostic factor after
hepatectomy for hepatocellular carcinoma. Int J Clin Oncol.
18:829–838. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miyagawa S, Makuuchi M, Kawasaki S and
Kakazu T: Criteria for safe hepatic resection. Am J Surg.
169:589–594. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Koch M, Garden OJ, Padbury R, Rahbari NN,
Adam R, Capussotti L, Fan ST, Yokoyama Y, Crawford M, Makuuchi M,
et al: Bile leakage after hepatobiliary and pancreatic surgery: A
definition and grading of severity by the International Study Group
of Liver Surgery. Surgery. 149:680–688. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mangram AJ, Horan TC, Pearson ML, Silver
LC and Jarvis WR: Guideline for prevention of surgical site
infection, 1999. Centers for disease control and prevention (CDC)
hospital infection control practices advisory committee. Am J
Infect Control. 27:97–134; 96. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ding PR, An X, Zhang RX, Fang YJ, Li LR,
Chen G, Wu XJ, Lu ZH, Lin JZ, Kong LH, et al: Elevated preoperative
neutrophil to lymphocyte ratio predicts risk of recurrence
following curative resection for stage IIA colon cancer. Int J
Colorectal Dis. 25:1427–1433. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shirai Y, Shiba H, Sakamoto T, Horiuchi T,
Haruki K, Fujiwara Y, Futagawa Y, Ohashi T and Yanaga K:
Preoperative platelet to lymphocyte ratio predicts outcome of
patients with pancreatic ductal adenocarcinoma after pancreatic
resection. Surgery. 158:360–365. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kasymjanova G, MacDonald N, Agulnik JS,
Cohen V, Pepe C, Kreisman H, Sharma R and Small D: The predictive
value of pre-treatment inflammatory markers in advanced
non-small-cell lung cancer. Curr Oncol. 17:52–58. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kanda M, Fujii T, Kodera Y, Nagai S,
Takeda S and Nakao A: Nutritional predictors of postoperative
outcome in pancreatic cancer. Br J Surg. 98:268–274. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
